The announcement of a proposed public offering by Praxis Precision Medicines (PRAX) is directly related to the company's stock. However, the size of the offering has not been disclosed, making it difficult to predict the short-term impact on the stock price. The news is important for investors as it may affect the company's valuation and share dilution, but the lack of details prevents a clear assessment of the direction of the stock price.